fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ISH/BSH 2016: Professor Graham Jackson (Newcastle-Upon-Tyne, UK) discusses the risk factors and patient characteristics that most inform treatment selection for patients with R/R MM. Also included article ‘Risk stratification in the older patient: what are our priorities?’

Written by | 31 May 2016

Risk stratification in the older patient: what are our priorities? by Maria Dalby Professor Sonja Zweegman, VU University Medical Centre, Amsterdam, NL Biological age and frailty, rather than… read more.

ISH/BSH 2016: Professor Graham Jackson (Newcastle-Upon-Tyne, UK) discusses the risk factors and patient characteristics that most inform treatment selection for patients with R/R MM. Also included article 'Risk stratification in the older patient: what are our priorities?'

Written by | 31 May 2016

Risk stratification in the older patient: what are our priorities? by Maria Dalby Professor Sonja Zweegman, VU University Medical Centre, Amsterdam, NL Biological age and frailty, rather than… read more.

ECCO 2016: Dr Charlie Lees (Edinburgh, UK) discusses in the video and article below the factors influencing the decision to stop treatment and discussed whether it may be possible to predict relapse using currently available methods

Written by | 9 May 2016

Stopping drugs – by Maria Dalby Charles Lees (Edinburgh, UK) Medication constitutes a large part of the IBD exposome, and stopping drug treatment should be a therapeutic goal… read more.

World Health Matters: Italy: Leukaemia death rate expected to fall in 2016

Written by | 22 Feb 2016

by Gary Finnegan: Good news in the battle against cancer: death rates from leukaemia among people of all ages in Europe are falling.

ASH 2015: Ixazomib shows promise in variety of settings, according to early trial results

Written by | 13 Jan 2016

by Thomas R. Collins: Fresh off its approval in the U.S. in the relapsed/refractory setting of multiple myeloma, ixazomib continues to be examined in other patient pools, with… read more.

ESOT 2015: Tailored self-management interventions for vulnerable populations

Written by | 20 Nov 2015

by Maria Dalby: Self-management after undergoing transplantation requires skills and confidence both with respect to taking medications, adhering to medical advice and coping with everyday life.

ESOT 2015: Tailor-made immunosuppression and post-transplant follow-up

Written by | 19 Nov 2015

by Maria Dalby: Advances in diagnostic techniques, genetic testing and immunosuppressive protocols allow clinicians to tailor interventions to the individual patient’s needs to a greater extent than in… read more.

IMV 2015: Newly diagnosed multiple myeloma, elderly patients: Professor Gareth Morgan, (Little Rock, USA) and Professor Paul Richardson, (Boston, USA) discuss managing older patients with MM

Written by | 18 Nov 2015

The majority of patients presenting with MM are elderly and pose a considerable clinical challenge in terms of disease burden and comorbidities compared with their younger counterparts. A… read more.

World Health Matters: Medications linked to falls in older men

Written by | 22 Oct 2015

by Gary Finnegan: Ireland: Medicines routinely prescribed for older patients may be contributing to elevated rates of falls in elderly men, according to a study published in the… read more.

World Health Matters (China): TB on the rise in older people

Written by | 8 Sep 2015

by Gary Finnegan: Preliminary findings presented at an international TB vaccine conference suggest older people are contributing to TB rates in China. Researchers say the development and introduction… read more.

ICML 2015 Report: Update on the revision of the WHO lymphoma classification

Written by | 28 Jul 2015

Steven H Swerdlow, University of Pittsburgh Medical Center, USA, / by Maria Dalby.  Knowledge is evolving fast in the field of lymphoma and the 2008 World Health Organization… read more.

Video Interview and editorial from the BSH 2015: Professor Graham Jackson discusses the journey from despair to hope in multiple myeloma. Click on the image for interview and editorial.

Written by | 1 Jun 2015

Graham Jackson, Professor of Clinical haematology, Newcastle upon Tyne and former president of the British Society for Haematology (BSH). Article by Christine Clark: In the 1970s the prospect… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.